![Si Ping Han](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Si Ping Han
Plus aucun poste en cours
Profil
Si Ping Han was the founder of Switch Therapeutics, Inc. and held the title of Chief Technology Officer, although they was no longer active in that role.
Anciens postes connus de Si Ping Han
Sociétés | Poste | Fin |
---|---|---|
Switch Therapeutics, Inc.
![]() Switch Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Switch Therapeutics, Inc. is an American biotechnology company that aims to treat a range of diseases affecting the central nervous system and systemic indications with significant unmet need. Switch is based in , and was founded by Dee Datta, who has been the CEO since incorporation. The company is pioneering a new type of medicine that integrates nucleic acid nanotechnology and RNA interference (RNAi) science. The company's novel gene knockdown approach, the Conditionally Activated siRNA (CASI) platform, is based on technology developed by renowned researchers in the field of RNA and drug development from Caltech, Harvard Medical School, and City of Hope. | Fondateur | 03/01/2024 |
Expériences
Fonctions occupées
Sociétés liées
Entreprise privées | 1 |
---|---|
Switch Therapeutics, Inc.
![]() Switch Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Switch Therapeutics, Inc. is an American biotechnology company that aims to treat a range of diseases affecting the central nervous system and systemic indications with significant unmet need. Switch is based in , and was founded by Dee Datta, who has been the CEO since incorporation. The company is pioneering a new type of medicine that integrates nucleic acid nanotechnology and RNA interference (RNAi) science. The company's novel gene knockdown approach, the Conditionally Activated siRNA (CASI) platform, is based on technology developed by renowned researchers in the field of RNA and drug development from Caltech, Harvard Medical School, and City of Hope. | Health Technology |